Evidence map›Paper›PMID 32297475›Full record

ArticleJournal of thrombosis and haemostasis : JTH2020

SLC44A2 deficient mice have a reduced response in stenosis but not in hypercoagulability driven venous thrombosis.

Julia Tilburg, Daniëlle M Coenen, Gaia Zirka, Sophie Dólleman, Annemarie M van Oeveren-Rietdijk, Mieke F A Karel, Hetty C de Boer, Judith M E M Cosemans, Henri H Versteeg, Pierre E Morange and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Platelet-Neutrophil Crosstalk in Thrombosis.International journal of molecular sciences · 2023
    Review
  5. Review
  6. Review
  7. Review
  8. The role of bone marrow-derived cells in venous thromboembolism.The international journal of biochemistry & cell biology · 2020
    Review
  9. Article
  10. Activated αeLife · 2020
    Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Julia TilburgDivision of Thrombosis and Hemostasis, Department of Internal Medicine, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, the Netherlands.ORCID 0000-0001-6135-5962
Daniëlle M CoenenDepartment of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.
Gaia ZirkaAix-Marseille Univ, INSERM, INRA, C2VN, Marseille, France.
Sophie DóllemanDivision of Nephrology, Department of Internal Medicine, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Annemarie M van Oeveren-RietdijkDivision of Nephrology, Department of Internal Medicine, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Mieke F A KarelDepartment of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.
Hetty C de BoerDivision of Nephrology, Department of Internal Medicine, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Judith M E M CosemansDepartment of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.
Henri H VersteegDivision of Thrombosis and Hemostasis, Department of Internal Medicine, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Pierre E MorangeAix-Marseille Univ, INSERM, INRA, C2VN, Marseille, France.ORCID 0000-0002-9065-722X
Bart J M van VlijmenDivision of Thrombosis and Hemostasis, Department of Internal Medicine, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Chrissta X MaracleDivision of Thrombosis and Hemostasis, Department of Internal Medicine, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Grace M ThomasAix-Marseille Univ, INSERM, INRA, C2VN, Marseille, France.ORCID 0000-0003-4502-7154
Leiden University Medical Center · NLInserm · FRMaastricht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGenome wide association studies (GWAS) identified SLC44A2 as a novel susceptibility gene for venous thrombosis (VT) and previous work established that SLC44A2 contributed to clot formation upon vascular injury.

objectiveTo further investigate the role of SLC44A2 in VT by utilizing SLC44A2 deficient mice (Slc44a2

methodsMice were included in a hypercoagulability model driven by siRNA-mediated hepatic gene silencing of anticoagulants Serpinc1 (antithrombin) and Proc (protein C) and a flow restriction (stenosis) model induced by partial ligation of the inferior vena cava.

resultsIn the hypercoagulability model, no effect in onset was observed in Slc44a2

conclusionsThese studies corroborate the original GWAS findings and establish a contributing role for SLC44A2 during the initiation of VT, with indications that this may be related to platelet-neutrophil interaction. The precise mechanism however remains elusive and warrants further investigation.

Indexed as

ThrombophiliaVenous ThrombosisAnimalsBlood PlateletsConstriction, PathologicDisease Models, AnimalGenome-Wide Association StudyMembrane Transport ProteinsMicePlatelet ActivationMembrane Transport ProteinsSLC44A2 protein, mouseanimal models of human diseasebasic science researchthrombosisvascular biologyvascular diseases

Identifiers

PMID32297475
PMCPMC7383581
OpenAlexW3016449273

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.